Breaking News Instant updates and real-time market news.

CELG

Celgene

$104.99

-1.69 (-1.58%)

10:27
01/08/18
01/08
10:27
01/08/18
10:27

Celgene acquisition has 'interesting' upside potential, says Canaccord

After Celgene announced a deal to acquire Impact Biosciences for up to $7B, including an upfront payment of $1.1B, Canaccord analyst John Newman said the latter's JAK2 asset for myelofibrosis, fedratinib, showed an "interesting" 55% response rate in patients resistant or intolerant to Jakafi, which provides an immediately approvable FDA indication. This "carefully structured transaction" provides Celgene with substantial upside, assuming FDA approval, said Newman, who keeps a Buy rating and $140 price target on Celgene shares.

  • 08

    Jan

  • 18

    Jan

  • 25

    Jan

  • 25

    Jan

  • 16

    Feb

  • 25

    Mar

CELG Celgene
$104.99

-1.69 (-1.58%)

01/03/18
WELS
01/03/18
UPGRADE
Target $53
WELS
Outperform
Arena Pharmaceuticals upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Jim Birchenough upgraded Arena Pharmaceuticals (ARNA) to Outperform and raised his price target for the shares to $53 from $19. The stock closed yesterday up 7% to $36.21. An improved FDA environment could facilitate approval of ralinepag in pulmonary arterial hypertension, Birchenough tells investors in a research note. He's upgrading the shares ahead of the Phase 2 data for S1P modulator etrasimod in ulcerative colitis. The analyst believes recent data from Celgene's (CELG) competing S1P modulator ozanimod "lowers the bar for differentiation." Both of Arena's assets "could attract large Pharma interest," Birchenough adds.
01/05/18
BOFA
01/05/18
DOWNGRADE
BOFA
Neutral
Celgene downgraded to Neutral from Buy at BofA/Merrill
01/05/18
BOFA
01/05/18
DOWNGRADE
BOFA
Neutral
Celgene downgraded to Neutral due to limited growth at BofA/Merrill
BofA/Merrill analyst Ying Huang upgraded Neutral from Buy and lowered its price target to $120 from $129 due to lack of catalysts, headwinds from Revlimid competition, and reduced product sales expectations.
01/08/18
DBAB
01/08/18
NO CHANGE
Target $110
DBAB
Buy
Celgene deal 'incremental negative' for Incyte, says Deutsche Bank
Deutsche Bank analyst Navin Jacob calls Celgene's (CELG) acquisition of Impact Biomedicines "one step" in the right direction. The analyst estimates Impact's Jak2 inhibitor fedratinib can achieve 20% of peak Jakafi sales in myelofibrosis and polycythemia vera, which translates to $1B. The asset fits Celgene's business and the $2.4B that the company is paying over the next two years "doesn't appear egregious for a commercial ready asset," Jacob tells investors in a research note. The analyst also views Celgene's acquisition as an "incremental negative" for Incyte (INCY). Given direct overlap, any future potential acquisition of Incyte by Celgene has been removed, Jacob contends. He keeps a Hold rating on Celgene with a $110 price target.

TODAY'S FREE FLY STORIES

UNP

Union Pacific

$144.26

1.36 (0.95%)

07:59
05/24/18
05/24
07:59
05/24/18
07:59
Initiation
Union Pacific initiated  »

Union Pacific resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

NCR

NCR Corp.

$30.75

-0.4 (-1.28%)

07:58
05/24/18
05/24
07:58
05/24/18
07:58
Recommendations
NCR Corp. analyst commentary  »

NCR Corp. price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:55
05/24/18
05/24
07:55
05/24/18
07:55
Conference/Events
Federal Reserve Bank of Philadelphia President speaks at a conference »

Philadelphia Federal…

MCRB

Seres Therapeutics

$8.12

0.16 (2.01%)

07:55
05/24/18
05/24
07:55
05/24/18
07:55
Conference/Events
Seres Therapeutics to hold a research and development day »

Microbiome Research &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 02

    Jun

OKTA

Okta

$49.49

0.99 (2.04%)

07:52
05/24/18
05/24
07:52
05/24/18
07:52
Recommendations
Okta analyst commentary  »

Okta price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 06

    Jun

  • 12

    Jun

INTU

Intuit

$196.15

5.74 (3.01%)

07:51
05/24/18
05/24
07:51
05/24/18
07:51
Recommendations
Intuit analyst commentary  »

Intuit price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

CIT

CIT Group

$55.27

-0.06 (-0.11%)

07:51
05/24/18
05/24
07:51
05/24/18
07:51
Hot Stocks
CIT Group announces preliminary results of cash tender offer for common stock »

CIT Group announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EDU

New Oriental Education

$101.38

4.82 (4.99%)

07:50
05/24/18
05/24
07:50
05/24/18
07:50
Downgrade
New Oriental Education rating change  »

New Oriental Education…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

TAL

TAL Education

$43.74

1.11 (2.60%)

07:50
05/24/18
05/24
07:50
05/24/18
07:50
Upgrade
TAL Education rating change  »

TAL Education upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:48
05/24/18
05/24
07:48
05/24/18
07:48
Conference/Events
Federal Reserve Bank of Atlanta president delivers opening remarks at conference »

Atlanta Federal Reserve…

DRI

Darden

$85.72

-0.23 (-0.27%)

07:47
05/24/18
05/24
07:47
05/24/18
07:47
Recommendations
Darden analyst commentary  »

Darden added to Top Picks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

PBR

Petrobras

$15.10

-0.6 (-3.82%)

07:46
05/24/18
05/24
07:46
05/24/18
07:46
Downgrade
Petrobras rating change  »

Petrobras downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBR

Petrobras

$15.10

-0.6 (-3.82%)

07:46
05/24/18
05/24
07:46
05/24/18
07:46
Technical Analysis
Technical Take: Petrobras falls on diesel price cuts, regulator scrutiny »

The shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRPO

Precipio

$0.50

0.0143 (2.94%)

07:44
05/24/18
05/24
07:44
05/24/18
07:44
Hot Stocks
Precipio receives first order for liquid biopsy DNA enrichment sales in Europe »

Precipio entered into an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QURE

uniQure

$32.87

0.56 (1.73%)

07:44
05/24/18
05/24
07:44
05/24/18
07:44
Initiation
uniQure initiated  »

uniQure initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$98.72

1.16 (1.19%)

07:44
05/24/18
05/24
07:44
05/24/18
07:44
Recommendations
Microsoft analyst commentary  »

Microsoft stock should…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

WSM

Williams-Sonoma

$49.21

1.91 (4.04%)

07:39
05/24/18
05/24
07:39
05/24/18
07:39
Technical Analysis
Technical Take: Williams-Sonoma nears 52-week high after earnings beat »

The shares were last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LB

L Brands

$34.05

0.06 (0.18%)

07:38
05/24/18
05/24
07:38
05/24/18
07:38
Recommendations
L Brands analyst commentary  »

L Brands price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

GE

General Electric

$14.17

-1.13 (-7.39%)

07:37
05/24/18
05/24
07:37
05/24/18
07:37
Recommendations
General Electric analyst commentary  »

General Electric shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MIDD

Middleby

$104.42

1.88 (1.83%)

07:37
05/24/18
05/24
07:37
05/24/18
07:37
Initiation
Middleby initiated  »

Middleby initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

DE

Deere

$156.59

1.52 (0.98%)

07:36
05/24/18
05/24
07:36
05/24/18
07:36
Technical Analysis
Technical Take: Deere moves higher in pre-market, analyst action »

At time of writing the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAFM

Sanderson Farms

$107.13

1.19 (1.12%)

07:36
05/24/18
05/24
07:36
05/24/18
07:36
Hot Stocks
Sanderson Farms expects grain prices to be 'somewhat higher' in 2H »

"Looking ahead to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

TRP

TransCanada

$42.26

-0.72 (-1.68%)

07:35
05/24/18
05/24
07:35
05/24/18
07:35
Hot Stocks
TransCanada announces NEB recommendation of $1.4B North Montney Mainline Project »

TransCanada announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$30.45

-0.44 (-1.42%)

, JD

JD.com

$36.72

0.35 (0.96%)

07:35
05/24/18
05/24
07:35
05/24/18
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

BAC

Bank of America

$30.45

-0.44 (-1.42%)

JD

JD.com

$36.72

0.35 (0.96%)

TWX

Time Warner

$93.99

-0.43 (-0.46%)

MRK

Merck

$59.16

0.7 (1.20%)

EBAY

eBay

$38.04

0.27 (0.71%)

KMI

Kinder Morgan

$16.19

0.245 (1.54%)

GLW

Corning

$27.76

0.115 (0.42%)

SU

Suncor

$40.68

-0.36 (-0.88%)

GERN

Geron

$4.67

0.6 (14.74%)

CWH

Camping World

$19.28

-2.12 (-9.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 25

    May

  • 30

    May

  • 02

    Jun

  • 05

    Jun

  • 11

    Jun

  • 12

    Jun

  • 13

    Jun

  • 10

    Sep

  • 23

    Oct

CL

Colgate-Palmolive

$62.70

0.31 (0.50%)

07:33
05/24/18
05/24
07:33
05/24/18
07:33
Recommendations
Colgate-Palmolive analyst commentary  »

Colgate-Palmolive could…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.